A traditional Chinese herbal formula called Hepatoprotective Formula 919 reduced fat buildup in the livers of rats with diet-induced fatty liver disease by activating a metabolic protein called AMPK. According to Gram Research analysis, the formula improved multiple markers of liver health and fat metabolism while reducing inflammation-related genes. The treatment also shifted gut bacteria composition toward healthier patterns. However, this research was conducted in rats, so human clinical trials are needed before the formula can be recommended for treating fatty liver disease in people.
Researchers tested a traditional Chinese herbal blend called Hepatoprotective Formula 919 (HF919) on rats with fatty liver disease caused by a high-fat diet. According to Gram Research analysis, the formula reduced fat buildup in the liver and improved metabolic markers related to weight and energy use. The treatment worked by activating a protein called AMPK that helps the body burn fat more efficiently. The study also found changes in gut bacteria that may have contributed to the benefits. While these results are promising, the research was done in rats, so scientists need to test whether the formula works safely and effectively in people.
Key Statistics
A 2026 animal study published in Frontiers in Pharmacology found that Hepatoprotective Formula 919 increased hepatic phosphorylated AMPK abundance and reduced hepatic lipid accumulation in high-fat diet-induced NAFLD rats compared to untreated controls.
Research on Hepatoprotective Formula 919 showed the formula reduced expression of inflammation-related genes including Tlr4, Nfkb2, and Tgfb1 while increasing expression of Ppara, a gene that helps the body break down fatty acids.
The 2026 study found that treatment with Hepatoprotective Formula 919 significantly reduced the number of F4/80-positive immune cells in liver tissue and increased expression of macrophage-associated genes Mertk and Arg1, suggesting reduced harmful inflammation.
The Quick Take
- What they studied: Whether a traditional Chinese herbal formula could reduce fatty liver disease and improve how the body processes fats and energy
- Who participated: Laboratory rats fed a high-fat diet to mimic fatty liver disease in humans. The study compared treated rats to untreated control rats
- Key finding: The herbal formula reduced fat accumulation in the liver and activated a key metabolic protein called AMPK that helps the body burn fat more efficiently
- What it means for you: This research suggests a potential natural treatment for fatty liver disease, but human studies are needed before people should consider using it. Talk to your doctor before trying any herbal supplements
The Research Details
Scientists first identified the active compounds in Hepatoprotective Formula 919 using advanced laboratory techniques. They then used computer modeling to predict which compounds would be absorbed well by the body and which liver disease targets they might affect. The researchers studied human liver tissue data to understand which pathways are disrupted in fatty liver disease. Finally, they tested the formula in rats with diet-induced fatty liver disease, measuring changes in liver fat, blood markers, liver tissue under a microscope, and gene expression patterns.
The rat model is important because it closely mimics how fatty liver disease develops in humans from eating a high-fat diet. By using both computer predictions and animal testing, the researchers could identify the most promising mechanisms before considering human trials. The study also examined changes in gut bacteria as a secondary measure, since emerging research suggests gut health influences liver disease.
This research approach combines multiple scientific methods to understand not just whether a treatment works, but how it works at the molecular level. By integrating computer modeling, human tissue data, and animal testing, the researchers built a strong foundation for understanding the formula’s mechanisms. This multi-layered approach helps scientists decide whether a treatment is worth testing in humans and what to measure in future studies.
The study used rigorous methods including histological analysis (examining liver tissue under a microscope), biochemical measurements (blood and liver chemistry), molecular analysis (measuring specific genes and proteins), and immunohistochemistry (using special stains to visualize specific cells). The researchers also validated their findings using public human liver tissue data, which strengthens confidence in the relevance to human disease. However, this is an animal study, so results may not directly translate to humans. The study was exploratory in nature, meaning some findings need confirmation in future research
What the Results Show
Hepatoprotective Formula 919 significantly reduced fat accumulation in the livers of rats fed a high-fat diet. The treated rats showed improvements in multiple markers of liver health and fat metabolism compared to untreated rats. The formula increased levels of a key metabolic protein called phosphorylated AMPK, which acts like a cellular energy sensor that tells the body to burn fat more efficiently.
The treatment also increased expression of a gene called Ppara, which helps the body break down fatty acids. At the same time, the formula reduced expression of genes associated with inflammation and liver injury, including Tlr4, Nfkb2, and Tgfb1. These changes suggest the formula works through multiple pathways to reduce both fat accumulation and inflammation in the liver.
The researchers also observed reduced numbers of immune cells called macrophages in the liver tissue of treated rats, along with changes in macrophage-related genes that suggest a shift toward less inflammatory immune activity. This indicates the formula may reduce harmful inflammation in addition to improving fat metabolism.
Analysis of fecal samples showed that the formula shifted the composition of gut bacteria toward patterns seen in healthy control rats. Specifically, several short-chain fatty acids (SCFAs), which are beneficial compounds produced by gut bacteria, changed in treated rats. These changes in gut bacteria composition were associated with improvements in liver metabolic markers, suggesting the gut microbiome may play a role in the formula’s benefits. This finding opens new questions about how herbal treatments might work through effects on gut health
This research aligns with growing evidence that AMPK activation is a promising target for treating fatty liver disease. Previous studies have shown that activating AMPK can reduce fat accumulation and improve metabolic health. The finding that gut bacteria changes accompany the benefits is consistent with emerging research showing the gut microbiome influences liver disease. However, most previous studies of herbal formulas for fatty liver disease have been smaller or less mechanistically detailed, so this multi-method approach provides more comprehensive evidence for how the formula might work
This study was conducted entirely in rats, so results may not directly apply to humans. Rats metabolize compounds differently than people, and their disease may not perfectly match human fatty liver disease. The study did not test different doses of the formula or compare it to existing treatments for fatty liver disease. The sample size of rats was not clearly specified in the abstract. Some findings, particularly the gut bacteria analysis, were described as exploratory, meaning they need confirmation in future studies. The researchers note that further studies are needed to prove AMPK activation is actually responsible for the benefits, rather than just associated with them
The Bottom Line
This research provides moderate evidence that Hepatoprotective Formula 919 may help treat fatty liver disease through AMPK activation and metabolic improvements. However, human clinical trials are needed before this formula can be recommended for patient use. People with fatty liver disease should continue following established treatments (weight loss, exercise, dietary changes) and consult their doctor before trying herbal supplements. The formula shows promise but is not yet proven safe or effective in humans
This research is most relevant to people with non-alcoholic fatty liver disease (NAFLD) and researchers studying metabolic disease. Hepatologists (liver specialists) and integrative medicine practitioners may find this work interesting. People with fatty liver disease should not self-treat with this formula based on animal studies alone. Healthcare providers should wait for human clinical trials before recommending it to patients
In the rat model, the formula showed effects within the timeframe of the study, but the exact duration of treatment was not specified in the abstract. If the formula eventually reaches human trials, it typically takes 8 to 12 weeks to see measurable improvements in liver fat and metabolic markers. Full reversal of fatty liver disease usually requires sustained lifestyle changes over months to years
Frequently Asked Questions
Can I use this Chinese herbal formula to treat my fatty liver disease?
Not yet. This formula has only been tested in rats, not humans. While results are promising, you need human clinical trials before it can be recommended. Talk to your doctor about proven treatments like weight loss, exercise, and dietary changes
How does Hepatoprotective Formula 919 reduce fatty liver disease?
The formula activates a protein called AMPK that acts as a metabolic switch, telling your body to burn fat more efficiently. It also reduces inflammation in the liver and may improve gut bacteria composition, which influences liver health
What is AMPK and why is it important for liver health?
AMPK is a cellular energy sensor that regulates how your body uses and stores fat. When activated, AMPK increases fat burning and reduces fat storage. Research shows people with fatty liver disease have lower AMPK activity, making it a promising treatment target
When will this formula be available for human use?
Unknown. The formula must first pass human clinical trials to prove safety and effectiveness. This typically takes several years. Researchers recommend further mechanistic studies before human trials begin
Are there proven treatments for fatty liver disease I can use now?
Yes. Weight loss of 5 to 10 percent of body weight, regular exercise (150 minutes weekly), reducing refined carbohydrates and saturated fats, and limiting alcohol all reduce fatty liver disease. Talk to your doctor about these evidence-based approaches
Want to Apply This Research?
- Users could track liver health markers if they eventually have access to this treatment: measure liver enzyme levels (ALT, AST) every 4 to 8 weeks through blood tests, and monitor waist circumference and body weight weekly as indirect measures of metabolic improvement
- While waiting for human trials, users should focus on proven interventions: reduce high-fat food intake, increase physical activity to 150 minutes per week, and track daily steps or exercise minutes. These changes activate the same AMPK pathways that the formula targets
- Establish a baseline of liver enzyme levels and metabolic markers through your doctor. If the formula becomes available for human use, retest these markers every 8 to 12 weeks. Track weight, waist circumference, and energy levels weekly. Report any side effects or changes in medications to your healthcare provider immediately
This research was conducted in laboratory rats and has not been tested in humans. Hepatoprotective Formula 919 is not approved by the FDA for treating fatty liver disease or any other condition. Do not use this formula to treat or prevent any disease without consulting your healthcare provider. This article is for educational purposes only and should not replace professional medical advice. If you have fatty liver disease, work with your doctor to develop a treatment plan based on proven interventions including weight loss, exercise, and dietary changes. Always inform your healthcare provider about any herbal supplements you are considering, as they may interact with medications or have unknown side effects
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.